Brazil agency claims Sinovac shot safe
Print Edition
BRAZIL’S state-run Butantan Institute on Wednesday announced that the CoronaVac vaccine developed by the private Chinese laboratory Sinovac Life Science achieved the levels of efficacy against the coronavirus required by the World Health Organization in trials with 13,000 Brazilian volunteers.
“The data corroborate that it is the safest vaccine on the market and we achieved the superiority in efficacy required by the WHO and Brazil’s Health Regulatory Agency,” Dimas Covas, director of the institute, said at a press conference.
The level of efficacy required by the WHO is greater than 50 percent, he said.
“We have reached the level of effectiveness that allows us to request the registration for emergency use of the vaccine both here and in China. It is a historic day for Brazilian science because of the hope it brings to Brazilians,” said Covas.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
